contraindications for glp-1 agonists Independent Nurse - and GIP/GLP-1 receptor type 2 diabetes Mapping the effectiveness and risks
Description
Rode, A
If pancreatitis is suspected, the patient should discontinue exenatide immediately and seek medical attention
Similar effect was obtained with escalation of dulaglutide from 1.5 mg to 3 mg or 4.5 mg
Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy
